COPYRIGHT © DIGITAL JOURNAL INC. Sitemaps: XML / News. Digital Journal is not responsible for the content of external sites. Read more about our external linking
United States, Nevada, Las Vegas, DelveInsight’s “Schizophrenia – Market Insight, Epidemiology and Market Forecast – 2032” report provides current treatment practices, emerging drugs, Schizophrenia market share of the individual therapies, current and forecasted Schizophrenia market size from 2019 to 2032 segmented by seven major markets. The report also offers current Schizophrenia therapy algorithms, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the Schizophrenia market.
Schizophrenia Overview
Schizophrenia is a severe mental disorder in which people interpret reality abnormally. It may result in hallucinations, delusions, and extremely disordered thinking and behavior that impairs daily functioning and can be disabling. Contrary to public perception, schizophrenia is not a split or multiple personalities. Besides, it is not caused by childhood experiences, poor parenting, or lack of willpower, nor the symptoms are identical in each patient. In addition, the vast majority of people with schizophrenia are not violent and do not pose a danger to others.
In some people, schizophrenia appears suddenly and without warning. But for most, it comes on slowly, with subtle warning signs and a gradual decline in functioning long before the first severe episode. Often, friends or family members will know early on that something is wrong without knowing exactly what.
Schizophrenia Epidemiological Insights
In the year 2021, the total prevalent cases of Schizophrenia were 6.27 million in the 7MM which are expected to grow during the study period, i.e., 2019–2032.
Schizophrenia Treatment Market
Schizophrenia is a lifelong condition, but effective treatment can help a person manage the symptoms, prevent relapses, and avoid hospitalization. Schizophrenia requires lifelong treatment, even when symptoms have subsided. Treatment with medications and psychosocial therapy can help manage the condition; in some cases, hospitalization may be needed.
A psychiatrist experienced in treating schizophrenia usually guides treatment. The treatment team also may include a psychologist, social worker, psychiatric nurse, and possibly a case manager to coordinate care. The full-team approach may be available in clinics with expertise in schizophrenia treatment.
Schizophrenia requires a combination of treatments, including medication (antipsychotics), psychological counseling and social support, cognitive behavioral therapy, and electroconvulsive therapy (ECT).
Discover more about Schizophrenia treatment therapies in the pipeline @ Schizophrenia Drugs
Leading Companies Working in the Schizophrenia Market
To understand key companies related to the Schizophrenia Market, get a snapshot of the Schizophrenia Regulatory and Patent Analysis.
Scope of the Schizophrenia Market Report
Study Period: 2019–2032
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), Japan]
Key Schizophrenia Companies: Boehringer Ingelheim, Karuna Therapeutics, Acadia Pharmaceuticals, Reviva Pharmaceuticals, Sunivion/PsychoGenics, Otsuka Pharmaceuticals, Neurocrine Biosciences, Takeda, Minerva Neurosciences, Newron Pharmaceuticals, Lyndra Therapeutics, Pharmaceuticals Laboratories, Cerevel Therapeutics, and others
Therapeutic Assessment: Schizophrenia current marketed and emerging therapies
Schizophrenia Market Dynamics: Schizophrenia market drivers and barriers
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
Unmet Needs, KOL’s views, Analyst’s views, Schizophrenia Market Access and Reimbursement
Table of Contents
Leading Reports by DelveInsight:
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.
Contact Us
Kritika Rehani
info@delveinsight.com
+1(919)321-6187